« Previous
Next »
Academic Radiology
Volume 13, Issue 6
, Pages 721-727
, June 2006
Inversion Recovery MRI in Idiopathic Parkinson Disease Is a Very Sensitive Tool to Assess Neurodegeneration in the Substantia Nigra: Preliminary Investigation
References
-
.
An essay on the shaking palsy
. London: Whittingham & Rowland; 1817;
- . Parkinson’s disease. First of two parts . N Engl J Med . 1998;339:1044–1053
- . Parkinson’s disease. Second of two parts . N Engl J Med . 1998;339:1130–1143
-
.
Parkinson’s disease
(a novel MRI method for determining the structural changes in the substantia nigra)
.
J Neurol Neurosurg Psychiatr
. 1999;67:815–818
- . Structural changes in the substantia nigra in Parkinson’s disease as revealed by MR imaging . AJNR Am J Neuroradiol . 2000;21:697–701
- . MRI correlates of pathology in parkinsonism (segmented inversion recovery ratio imaging (SIRRIM)) . NeuroImage . 2003;20:1899–1902
- . Computer assessment of neurodegeneration in Parkinson disease using data fusion techniques with MR images . Acad Radiol . 2003;10:1036–1044
-
.
Unified Parkinson’s disease rating scale
.
In:
Fahn S
, Marsden CD
, Calne D
, Goldstein M
editor.
Recent Developments in Parkinson’s Disease
. 2:
London: Macmillan; 1987;p. 293–304
- . Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Commentary . Bethesda, Md Clin Pharmacol Ther . 2001;69:89–95
- . The use of PET in Parkinson’s disease . Brain Cogn . 1995;28:297–301
- Separating Parkinson’s disease from normality. Discriminant function analysis of fluorodopa F18 positron emission tomography data . Arch Neurol . 1994;51:237–243
- . The detection of preclinical Parkinson’s disease (what is the role of positron emission tomography?) . Mov Disord . 1993;8:271–277
- . A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease . Neurology . 2001;56:1195–1200
- . Etiology of Parkinson’s disease (contributions from 18F-DOPA positron emission tomography) . Adv Neurol . 1999;80:227–231
- [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression . Neurology . 2001;57:2089–2094
- . Importance of magnetic resonance in Parkinson disease. An analytic study of the pars compacta . Acta Med Port . 1990;3:85–88
- . Magnetic resonance imaging in Parkinson’s disease and parkinsonian syndromes . Neurology . 1989;39:1524–1526
- . Increased iron-related MRI contrast in the substantia nigra in Parkinson’s disease [published erratum in Neurology 1995; 45:1420] . Neurology . 1995;45:1138–1143
- . T2 relaxation time in patients with Parkinson’s disease . Neurology . 1993;43:697–700
- . Magnetic resonance imaging in Parkinson’s disease—the evaluation of the width of the substantia pars compacta on T2 weighted images . Rinsho Shinkeigaku . 1992;32:8–12
-
.
Pattern classification by distance functions
.
In:
Pattern Recognition Principles. Edition 1981 (revived and scanned version)
. Boston, MA: Addison-Wesley; 1999;p. 94–97
-
.
Aging and Parkinson’s disease
(substantia nigra regional selectivity)
.
Brain
. 1991;114:2283–2301
- . The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry . Brain . 1999;122:1421–1436
- . The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease . Brain . 1999;122:1437–1448
-
.
Compositing digital images
.
Comp Graphics
. 1984;18:253–259
-
.
Familial Parkinson’s disease
.
Neurosci News
. 1998;1:43–46
- . Is Parkinson’s disease an inherited condition? . Adv Neurol . 1999;80:143–152
- Environmental risk factors in Parkinson’s disease . Neurology . 1990;40:1218–1221
- Environmental and genetic risk factors in Parkinson’s disease (a case-control study in southern Italy) . Mov Disord . 1996;11:17–23
-
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson’s disease
.
Mov Disord
. 2006;20(21):299–305
- . Levodopa and the progression of Parkinson’s disease . N Engl J Med . 2004;351:2498–2508
1 This study was supported in part by the Myra Fox and Max Smedresman Funds for Research into Parkinson’s disease (NYU School of Medicine; M.H., U.R.) and partial support from the DICYT of the University of Santiago de Chile (grant 020531RB).
PII: S1076-6332(06)00078-X
doi: 10.1016/j.acra.2006.01.049
© 2006 AUR. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Academic Radiology
Volume 13, Issue 6
, Pages 721-727
, June 2006
